Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report.

We report the case of a patient with early post-transplant thrombotic microangiopathy after lung transplantation that was treated with basiliximab. Switching from calcineurin inhibitors using basiliximab may be an option for treating thrombotic microangiopathy without increasing the risk of acute rejection.